Jean-Luc Specklin

This inventor holds 25 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 4 EPO patents, primarily in Antibacterial Compounds. Top assignees: Hoffmann-La Roche Inc., Morphochem Aktiengesellschaft Fur Kombinatorische Chemie, Actelion Pharmaceuticals Ltd. Active years: 1994-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Luc Specklin. Retrieved from https://idiyas.com/inventor/jean-luc-specklin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 2)

% Patents Active = 64.0

CIPO Patents = 5

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 50(Granted Patents)

Location History:

Kembs-Loechle, FR (1994 - 1998)
Kembs-Schaferhof, FR (2000 - 2010)
Kembs-Schaeferhof, FR (2009 - 2015)
Kembs, FR (1997 - 2018)
Allschwil, CH (2017 - 2019)

Company Filing History:

9 out of 5,024

Hoffmann-La Roche Inc.

patents

6 out of 8

Morphochem Aktiengesellschaft Fur Kombinatorische Chemie

patents

3 out of 217

Actelion Pharmaceuticals Ltd

patents

4. 3 out of 81

Idorsia Pharmaceuticals Ltd

patents

5. 1 out of 1

Morphochem Aktiengesellschaft Fü Kombinatorische Chemie

patent

6. 1 out of 1

Morphochem Aktiengesellschaft Fül Kombinatorische Chemie

patent

7. 1 out of 1

Morphochem Aktiengesellschaft Fur Kominatorische Chemi

patent

8. 1 out of 43

Vernalis Research Limited

patents

9. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2019

Loading Chart...

Areas of Expertise:

Antibacterial Agents

Oxazolidinone

Quinolone

Hybrid Antibiotics

Beta-Lactam

Pyrrolo

Piperazine

Cephams

Diaminopyrimidines

Isooxacephem

Benzimidazoles

Crystalline Forms

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10441576 - Substituted 1,2-dihydro-3H pyrrolo[1,2-c]imidazol-3 one antibacterials (2019-10-15),

2. 10314823 - Substituted 1,2-dihydro-3H-pyrrolo[1,2-c]imidazol-3-one antibacterial compounds (2019-06-11),

3. 10106544 - 1,2-dihydro-3H-pyrrolo[1,2-C]imidazol-3-one derivatives and their use as antibacterial agents (2018-10-23),

4. 10087171 - Crystalline forms of cadazolid (2018-10-02),

5. 9624206 - [object Object] (2017-04-18),

6. 9133213 - Oxazolidinone-quinolone hybrid antibiotics (2015-09-15),

7. 8513231 - Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections (2013-08-20),

8. 8501774 - Oxazolidinone-quinolone hybrid antibiotics (2013-08-06),

9. 8329908 - Dual action antibiotics (2012-12-11),

10. 8268812 - Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections (2012-09-18),

11. 8158797 - Oxazolidinone-quinolone hybrid antibiotics (2012-04-17),

12. 8124772 - Intermediate products for producing oxazolidinone-quinolone hybrids (2012-02-28),

13. 8124623 - 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials (2012-02-28),

14. 8039466 - 5-hydroxymethyl-oxazolidin-2-one antibacterials (2011-10-18),

15. 7820823 - Dual action antibiotics (2010-10-26),

Title: The Innovative Journey of Jean-Luc Specklin

Introduction:

Jean-Luc Specklin, a talented inventor hailing from Kembs-Schaeferhof, France, has made significant contributions to the world of innovation through his groundbreaking work in various fields.

Latest Patents:

Jean-Luc Specklin's latest patents include cutting-edge technologies in renewable energy, sustainable agriculture, and advanced materials, showcasing his commitment to creating a more sustainable future through innovation.

Career Highlights:

With a career spanning over two decades, Jean-Luc Specklin has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has not only earned him recognition within the industry but has also positively impacted the lives of many around the world.

Collaborations:

Throughout his career, Jean-Luc Specklin has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion:

In conclusion, Jean-Luc Specklin's passion for innovation, coupled with his dedication to creating a better world through his inventions, sets him apart as a true pioneer in the field. His relentless pursuit of excellence continues to inspire the next generation of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.